T-bet+CD8+ T细胞在微卫星稳定的胃癌中控制抗PD-1反应

Shiying Tang1,2,3,4, Xiaofang Che1,2,3,4, Jinyan Wang5

  • 1Department of Medical Oncology, The First Hospital of China Medical University, No. 155, Nanjing Street, Shenyang, Liaoning, China.

Nature communications
|April 25, 2025
PubMed
概括

研究人员开发了一种方法来识别可能对免疫检查点抑制剂 (ICI) 产生反应的微卫星稳定胃癌患者. 这种方法针对T-bet+ CD8+ T细胞,增强抗瘤免疫力,以获得更好的ICI治疗结果.